These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32560398)

  • 21. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases.
    Visniauskas B; Kilanowski-Doroh I; Ogola BO; Mcnally AB; Horton AC; Imulinde Sugi A; Lindsey SH
    J Hum Hypertens; 2023 Aug; 37(8):609-618. PubMed ID: 36319856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
    Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
    Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.
    Revankar CM; Bologa CG; Pepermans RA; Sharma G; Petrie WK; Alcon SN; Field AS; Ramesh C; Parker MA; Savchuk NP; Sklar LA; Hathaway HJ; Arterburn JB; Oprea TI; Prossnitz ER
    Cell Chem Biol; 2019 Dec; 26(12):1692-1702.e5. PubMed ID: 31706983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and the cardiovascular system.
    Knowlton AA; Lee AR
    Pharmacol Ther; 2012 Jul; 135(1):54-70. PubMed ID: 22484805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors.
    Jacenik D; Cygankiewicz AI; Mokrowiecka A; Małecka-Panas E; Fichna J; Krajewska WM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
    Nakamura Y; Suzuki T; Miki Y; Tazawa C; Senzaki K; Moriya T; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):17-26. PubMed ID: 15149723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.
    Boese AC; Kim SC; Yin KJ; Lee JP; Hamblin MH
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H524-H545. PubMed ID: 28626075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies.
    Sanz-González SM; Cano A; Valverde MA; Hermenegildo C; Andrés V
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):107-22. PubMed ID: 15320794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled estrogen receptor regulates embryonic heart rate in zebrafish.
    Romano SN; Edwards HE; Souder JP; Ryan KJ; Cui X; Gorelick DA
    PLoS Genet; 2017 Oct; 13(10):e1007069. PubMed ID: 29065151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
    Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
    Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia.
    Meng Q; Li J; Chao Y; Bi Y; Zhang W; Zhang Y; Ji T; Fu Y; Chen Q; Zhang Q; Li Y; Bian H
    Biochem Pharmacol; 2020 Oct; 180():114134. PubMed ID: 32628929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
    Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
    Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen signaling and cardiovascular disease.
    Murphy E
    Circ Res; 2011 Sep; 109(6):687-96. PubMed ID: 21885836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Position paper: The membrane estrogen receptor GPER--Clues and questions.
    Barton M
    Steroids; 2012 Aug; 77(10):935-42. PubMed ID: 22521564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of G-Protein Coupled Receptor 30 (GPR30) on Endothelial Inflammation.
    Chakrabarti S; Davidge ST
    Methods Mol Biol; 2016; 1366():503-516. PubMed ID: 26585160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system.
    Ueda K; Karas RH
    Steroids; 2013 Jun; 78(6):589-96. PubMed ID: 23276634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G protein-coupled estrogen receptor 1 as a novel regulator of blood pressure.
    Gohar EY
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F612-F617. PubMed ID: 32893662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical review of fundamental controversies in the field of GPR30 research.
    Langer G; Bader B; Meoli L; Isensee J; Delbeck M; Noppinger PR; Otto C
    Steroids; 2010; 75(8-9):603-10. PubMed ID: 20034504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.